Table of Contents 1 Recurrent Glioblastoma Multiforme (GBM) Treatment Market Overview 1.1 Product Overview and Scope of Recurrent Glioblastoma Multiforme (GBM) Treatment 1.2 Classification of Recurrent Glioblastoma Multiforme (GBM) Treatment by Types 1.2.1 Global Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue Comparison by Types (2017-2023) 1.2.2 Global Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue Market Share by Types in 2017 1.2.3 Oral Medications 1.2.4 Temozolomide 1.2.5 Radiosensitizers 1.2.6 Nitrosoureas Drugs 1.2.7 Radiation Therapy 1.2.8 Chemotherapy 1.3 Global Recurrent Glioblastoma Multiforme (GBM) Treatment Market by Application 1.3.1 Global Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size and Market Share Comparison by Applications (2013-2023) 1.3.2 Hospitals 1.3.3 Clinics 1.3.4 Ambulatory Surgical Centers 1.4 Global Recurrent Glioblastoma Multiforme (GBM) Treatment Market by Regions 1.4.1 Global Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size (Million USD) Comparison by Regions (2013-2023) 1.4.1 North America (USA, Canada and Mexico) Recurrent Glioblastoma Multiforme (GBM) Treatment Status and Prospect (2013-2023) 1.4.2 Europe (Germany, France, UK, Russia and Italy) Recurrent Glioblastoma Multiforme (GBM) Treatment Status and Prospect (2013-2023) 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Recurrent Glioblastoma Multiforme (GBM) Treatment Status and Prospect (2013-2023) 1.4.4 South America (Brazil, Argentina, Colombia) Recurrent Glioblastoma Multiforme (GBM) Treatment Status and Prospect (2013-2023) 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Recurrent Glioblastoma Multiforme (GBM) Treatment Status and Prospect (2013-2023) 1.5 Global Market Size of Recurrent Glioblastoma Multiforme (GBM) Treatment (2013-2023) 2 Manufacturers Profiles 2.1 Astrazeneca 2.1.1 Business Overview 2.1.2 Recurrent Glioblastoma Multiforme (GBM) Treatment Type and Applications 2.1.2.1 Product A 2.1.2.2 Product B 2.1.3 Astrazeneca Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue, Gross Margin and Market Share (2016-2017) 2.2 Roche 2.2.1 Business Overview 2.2.2 Recurrent Glioblastoma Multiforme (GBM) Treatment Type and Applications 2.2.2.1 Product A 2.2.2.2 Product B 2.2.3 Roche Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue, Gross Margin and Market Share (2016-2017) 2.3 GlaxoSmithKline 2.3.1 Business Overview 2.3.2 Recurrent Glioblastoma Multiforme (GBM) Treatment Type and Applications 2.3.2.1 Product A 2.3.2.2 Product B 2.3.3 GlaxoSmithKline Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue, Gross Margin and Market Share (2016-2017) 2.4 Merck 2.4.1 Business Overview 2.4.2 Recurrent Glioblastoma Multiforme (GBM) Treatment Type and Applications 2.4.2.1 Product A 2.4.2.2 Product B 2.4.3 Merck Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue, Gross Margin and Market Share (2016-2017) 2.5 Pfizer 2.5.1 Business Overview 2.5.2 Recurrent Glioblastoma Multiforme (GBM) Treatment Type and Applications 2.5.2.1 Product A 2.5.2.2 Product B 2.5.3 Pfizer Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue, Gross Margin and Market Share (2016-2017) 2.6 AngioChem 2.6.1 Business Overview 2.6.2 Recurrent Glioblastoma Multiforme (GBM) Treatment Type and Applications 2.6.2.1 Product A 2.6.2.2 Product B 2.6.3 AngioChem Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue, Gross Margin and Market Share (2016-2017) 2.7 Vascular Biogeneics 2.7.1 Business Overview 2.7.2 Recurrent Glioblastoma Multiforme (GBM) Treatment Type and Applications 2.7.2.1 Product A 2.7.2.2 Product B 2.7.3 Vascular Biogeneics Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue, Gross Margin and Market Share (2016-2017) 3 Global Recurrent Glioblastoma Multiforme (GBM) Treatment Market Competition, by Players 3.1 Global Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue and Share by Players (2013-2018) 3.2 Market Concentration Rate 3.2.1 Top 5 Recurrent Glioblastoma Multiforme (GBM) Treatment Players Market Share 3.2.2 Top 10 Recurrent Glioblastoma Multiforme (GBM) Treatment Players Market Share 3.3 Market Competition Trend 4 Global Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size by Regions 4.1 Global Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue and Market Share by Regions 4.2 North America Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue and Growth Rate (2013-2018) 4.3 Europe Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue and Growth Rate (2013-2018) 4.4 Asia-Pacific Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue and Growth Rate (2013-2018) 4.5 South America Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue and Growth Rate (2013-2018) 4.6 Middle East and Africa Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue and Growth Rate (2013-2018) 5 North America Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue by Countries 5.1 North America Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue by Countries (2013-2018) 5.2 USA Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue and Growth Rate (2013-2018) 5.3 Canada Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue and Growth Rate (2013-2018) 5.4 Mexico Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue and Growth Rate (2013-2018) 6 Europe Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue by Countries 6.1 Europe Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue by Countries (2013-2018) 6.2 Germany Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue and Growth Rate (2013-2018) 6.3 UK Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue and Growth Rate (2013-2018) 6.4 France Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue and Growth Rate (2013-2018) 6.5 Russia Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue and Growth Rate (2013-2018) 6.6 Italy Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue and Growth Rate (2013-2018) 7 Asia-Pacific Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue by Countries 7.1 Asia-Pacific Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue by Countries (2013-2018) 7.2 China Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue and Growth Rate (2013-2018) 7.3 Japan Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue and Growth Rate (2013-2018) 7.4 Korea Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue and Growth Rate (2013-2018) 7.5 India Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue and Growth Rate (2013-2018) 7.6 Southeast Asia Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue and Growth Rate (2013-2018) 8 South America Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue by Countries 8.1 South America Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue by Countries (2013-2018) 8.2 Brazil Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue and Growth Rate (2013-2018) 8.3 Argentina Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue and Growth Rate (2013-2018) 8.4 Colombia Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue and Growth Rate (2013-2018) 9 Middle East and Africa Revenue Recurrent Glioblastoma Multiforme (GBM) Treatment by Countries 9.1 Middle East and Africa Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue by Countries (2013-2018) 9.2 Saudi Arabia Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue and Growth Rate (2013-2018) 9.3 UAE Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue and Growth Rate (2013-2018) 9.4 Egypt Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue and Growth Rate (2013-2018) 9.5 Nigeria Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue and Growth Rate (2013-2018) 9.6 South Africa Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue and Growth Rate (2013-2018) 10 Global Recurrent Glioblastoma Multiforme (GBM) Treatment Market Segment by Type 10.1 Global Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue and Market Share by Type (2013-2018) 10.2 Global Recurrent Glioblastoma Multiforme (GBM) Treatment Market Forecast by Type (2018-2023) 10.3 Oral Medications Revenue Growth Rate (2013-2023) 10.4 Temozolomide Revenue Growth Rate (2013-2023) 10.5 Radiosensitizers Revenue Growth Rate (2013-2023) 10.6 Nitrosoureas Drugs Revenue Growth Rate (2013-2023) 10.7 Radiation Therapy Revenue Growth Rate (2013-2023) 10.8 Chemotherapy Revenue Growth Rate (2013-2023) 11 Global Recurrent Glioblastoma Multiforme (GBM) Treatment Market Segment by Application 11.1 Global Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue Market Share by Application (2013-2018) 11.2 Recurrent Glioblastoma Multiforme (GBM) Treatment Market Forecast by Application (2018-2023) 11.3 Hospitals Revenue Growth (2013-2018) 11.4 Clinics Revenue Growth (2013-2018) 11.5 Ambulatory Surgical Centers Revenue Growth (2013-2018) 12 Global Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size Forecast (2018-2023) 12.1 Global Recurrent Glioblastoma Multiforme (GBM) Treatment Market Size Forecast (2018-2023) 12.2 Global Recurrent Glioblastoma Multiforme (GBM) Treatment Market Forecast by Regions (2018-2023) 12.3 North America Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue Market Forecast (2018-2023) 12.4 Europe Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue Market Forecast (2018-2023) 12.5 Asia-Pacific Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue Market Forecast (2018-2023) 12.6 South America Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue Market Forecast (2018-2023) 12.7 Middle East and Africa Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue Market Forecast (2018-2023) 13 Research Findings and Conclusion 14 Appendix 14.1 Methodology 14.2 Data Source

List of Tables and Figures Figure Recurrent Glioblastoma Multiforme (GBM) Treatment Picture Table Product Specifications of Recurrent Glioblastoma Multiforme (GBM) Treatment Table Global Recurrent Glioblastoma Multiforme (GBM) Treatment and Revenue (Million USD) Market Split by Product Type Figure Global Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue Market Share by Types in 2017 Figure Oral Medications Picture Figure Temozolomide Picture Figure Radiosensitizers Picture Figure Nitrosoureas Drugs Picture Figure Radiation Therapy Picture Figure Chemotherapy Picture Table Global Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue (Million USD) by Application (2013-2023) Figure Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue Market Share by Applications in 2017 Figure Hospitals Picture Figure Clinics Picture Figure Ambulatory Surgical Centers Picture Table Global Market Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue (Million USD) Comparison by Regions 2013-2023 Figure North America Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue (Million USD) and Growth Rate (2013-2023) Figure Europe Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue (Million USD) and Growth Rate (2013-2023) Figure Asia-Pacific Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue (Million USD) and Growth Rate (2013-2023) Figure South America Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue (Million USD) and Growth Rate (2013-2023) Figure Middle East and Africa Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue (Million USD) and Growth Rate (2013-2023) Figure Global Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue (Million USD) and Growth Rate (2013-2023) Table Astrazeneca Basic Information, Manufacturing Base and Competitors Table Astrazeneca Recurrent Glioblastoma Multiforme (GBM) Treatment Type and Applications Table Astrazeneca Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue, Gross Margin and Market Share (2016-2017) Table Roche Basic Information, Manufacturing Base and Competitors Table Roche Recurrent Glioblastoma Multiforme (GBM) Treatment Type and Applications Table Roche Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue, Gross Margin and Market Share (2016-2017) Table GlaxoSmithKline Basic Information, Manufacturing Base and Competitors Table GlaxoSmithKline Recurrent Glioblastoma Multiforme (GBM) Treatment Type and Applications Table GlaxoSmithKline Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue, Gross Margin and Market Share (2016-2017) Table Merck Basic Information, Manufacturing Base and Competitors Table Merck Recurrent Glioblastoma Multiforme (GBM) Treatment Type and Applications Table Merck Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue, Gross Margin and Market Share (2016-2017) Table Pfizer Basic Information, Manufacturing Base and Competitors Table Pfizer Recurrent Glioblastoma Multiforme (GBM) Treatment Type and Applications Table Pfizer Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue, Gross Margin and Market Share (2016-2017) Table AngioChem Basic Information, Manufacturing Base and Competitors Table AngioChem Recurrent Glioblastoma Multiforme (GBM) Treatment Type and Applications Table AngioChem Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue, Gross Margin and Market Share (2016-2017) Table Vascular Biogeneics Basic Information, Manufacturing Base and Competitors Table Vascular Biogeneics Recurrent Glioblastoma Multiforme (GBM) Treatment Type and Applications Table Vascular Biogeneics Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue, Gross Margin and Market Share (2016-2017) Table Global Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue (Million USD) by Players (2013-2018) Table Global Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue Share by Players (2013-2018) Figure Global Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue Share by Players in 2016 Figure Global Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue Share by Players in 2017 Figure Global Top 5 Players Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue Market Share in 2017 Figure Global Top 10 Players Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue Market Share in 2017 Figure Global Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue (Million USD) and Growth Rate (%) (2013-2018) Table Global Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue (Million USD) by Regions (2013-2018) Table Global Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue Market Share by Regions (2013-2018) Figure Global Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue Market Share by Regions (2013-2018) Figure Global Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue Market Share by Regions in 2017 Figure North America Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue and Growth Rate (2013-2018) Figure Europe Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue and Growth Rate (2013-2018) Figure Asia-Pacific Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue and Growth Rate (2013-2018) Figure South America Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue and Growth Rate (2013-2018) Figure Middle East and Africa Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue and Growth Rate (2013-2018) Table North America Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue by Countries (2013-2018) Table North America Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue Market Share by Countries (2013-2018) Figure North America Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue Market Share by Countries (2013-2018) Figure North America Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue Market Share by Countries in 2017 Figure USA Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue and Growth Rate (2013-2018) Figure Canada Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue and Growth Rate (2013-2018) Figure Mexico Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue and Growth Rate (2013-2018) Table Europe Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue (Million USD) by Countries (2013-2018) Figure Europe Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue Market Share by Countries (2013-2018) Figure Europe Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue Market Share by Countries in 2017 Figure Germany Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue and Growth Rate (2013-2018) Figure UK Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue and Growth Rate (2013-2018) Figure France Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue and Growth Rate (2013-2018) Figure Russia Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue and Growth Rate (2013-2018) Figure Italy Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue and Growth Rate (2013-2018) Table Asia-Pacific Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue (Million USD) by Countries (2013-2018) Figure Asia-Pacific Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue Market Share by Countries (2013-2018) Figure Asia-Pacific Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue Market Share by Countries in 2017 Figure China Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue and Growth Rate (2013-2018) Figure Japan Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue and Growth Rate (2013-2018) Figure Korea Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue and Growth Rate (2013-2018) Figure India Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue and Growth Rate (2013-2018) Figure Southeast Asia Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue and Growth Rate (2013-2018) Table South America Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue by Countries (2013-2018) Table South America Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue Market Share by Countries (2013-2018) Figure South America Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue Market Share by Countries (2013-2018) Figure South America Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue Market Share by Countries in 2017 Figure Brazil Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue and Growth Rate (2013-2018) Figure Argentina Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue and Growth Rate (2013-2018) Figure Colombia Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue and Growth Rate (2013-2018) Table Middle East and Africa Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue (Million USD) by Countries (2013-2018) Table Middle East and Africa Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue Market Share by Countries (2013-2018) Figure Middle East and Africa Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue Market Share by Countries (2013-2018) Figure Middle East and Africa Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue Market Share by Countries in 2017 Figure Saudi Arabia Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue and Growth Rate (2013-2018) Figure UAE Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue and Growth Rate (2013-2018) Figure Egypt Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue and Growth Rate (2013-2018) Figure Nigeria Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue and Growth Rate (2013-2018) Figure South Africa Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue and Growth Rate (2013-2018) Table Global Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue (Million USD) by Type (2013-2018) Table Global Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue Share by Type (2013-2018) Figure Global Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue Share by Type (2013-2018) Figure Global Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue Share by Type in 2017 Table Global Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue Forecast by Type (2018-2023) Figure Global Recurrent Glioblastoma Multiforme (GBM) Treatment Market Share Forecast by Type (2018-2023) Figure Global Oral Medications Revenue Growth Rate (2013-2018) Figure Global Temozolomide Revenue Growth Rate (2013-2018) Figure Global Radiosensitizers Revenue Growth Rate (2013-2018) Figure Global Nitrosoureas Drugs Revenue Growth Rate (2013-2018) Figure Global Radiation Therapy Revenue Growth Rate (2013-2018) Figure Global Chemotherapy Revenue Growth Rate (2013-2018) Table Global Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue by Application (2013-2018) Table Global Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue Share by Application (2013-2018) Figure Global Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue Share by Application (2013-2018) Figure Global Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue Share by Application in 2017 Table Global Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue Forecast by Application (2018-2023) Figure Global Recurrent Glioblastoma Multiforme (GBM) Treatment Market Share Forecast by Application (2018-2023) Figure Global Hospitals Revenue Growth Rate (2013-2018) Figure Global Clinics Revenue Growth Rate (2013-2018) Figure Global Ambulatory Surgical Centers Revenue Growth Rate (2013-2018) Figure Global Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue (Million USD) and Growth Rate Forecast (2018 -2023) Table Global Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue (Million USD) Forecast by Regions (2018-2023) Figure Global Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue Market Share Forecast by Regions (2018-2023) Figure North America Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue Market Forecast (2018-2023) Figure Europe Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue Market Forecast (2018-2023) Figure Asia-Pacific Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue Market Forecast (2018-2023) Figure South America Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue Market Forecast (2018-2023) Figure Middle East and Africa Recurrent Glioblastoma Multiforme (GBM) Treatment Revenue Market Forecast (2018-2023)

Astrazeneca Roche GlaxoSmithKline Merck Pfizer AngioChem Vascular Biogeneics